TaymaaMayMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Clinical Fellow in Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital
Are you Dr. May?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St.
Brigham And Women's Hospital, Division Of Gyn Oncology
Boston, MA 02115Phone+1 617-732-8843
Summary
- Dr. Taymaa May, MD is an obstetrician/gynecologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Faulkner Hospital and is a Clinical Fellow in Obstetrics at Brigham and Women's Hospital.
Education & Training
Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2010 - 2013- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2004 - 2010
McGill University Faculty of MedicineClass of 2004
Certifications & Licensure
MA State Medical License 2010 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery.Liat Hogen, Thirushi Siriwardena, Lina Salman, Marcus Q Bernardini, Sarah E Ferguson
International Journal of Gynecological Cancer. 2025-01-15 - Anastomotic diversion rates following integration of indocyanine green fluorescence angiography in cytoreductive surgery for ovarian cancer.Lina Salman, Liat Hogen, Manjula Maganti, Taymaa May
International Journal of Gynecological Cancer. 2024-11-04 - 1 citationsLaparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: A LANCE Randomized Clinical Trial.J Alejandro Rauh-Hain, Alexander Melamed, René Pareja, Taymaa May, Abdulrahman Sinno
JAMA Network Open. 2024-11-04
Press Mentions
HIPEC for Recurrent, Platinum-Sensitive Ovarian Cancer Fails to Improve PFSDecember 3rd, 2024- Adding HIPEC Boosts Survival in Recurrent Ovarian CancerNovember 14th, 2024
